Identity
- Security key
- 16164
- Ticker
- GOSS
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2019-02-08
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- GOSS
Detail
Enriched 2026-08-14 20:47
- Market cap
- $86,819,177.83
- Shares outstanding (class)
- 488,846,722
- Shares outstanding (weighted)
- 488,846,722
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 162
- Location
- SAN DIEGO, CA
- Homepage
- https://www.gossamerbio.com
- Description
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).